TP53 appears to play a particularly important role in sarcomagenesis; 25–30% of tumors that develop in patients with germline TP53 mutations (patients with Li-Fraumeni syndrome) are sarcomas, specifically soft tissue sarcomas and osteosarcomas [9]. Here, TP53 is linked to soft tissue sarcoma.